Dolores Schendel
CEO and Chief Scientific Officer, Medigene AG
Meet Dolores Schendel
Dolores has been a member of the German Research Foundation, German Cancer Aid and the European Research Council. She joined Medigene in 2014, when the company acquired Trianta Immunotherapy.
She is passionate about bringing individualized immunotherapies from bench to bedside by moving herself and her team from in-depth research to the forefront of the biotech industry.